Researchers have developed new genome editing techniques that allow for rewriting genetic code with precision and efficiency comparable to word processing. They demonstrated this ability by replacing codon instances in E. coli cells and combining edits into novel strains. The techniques aim to add new functions, introduce safeguards against contamination, and establish viral resistance. Separately, other researchers have improved methods for producing blood cells from human stem cells, achieving blood cell markers in 84% of cells through optimized chemical treatments mimicking natural development. These advances could enable stem cell therapies for conditions like cancer and immune disorders.